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EMCVNoxa is a Bcl-2 homology domain-containing pro-apoptotic mitochondrial protein. Noxa mRNA and protein
expression are upregulated by dsRNA or virus, and ectopic Noxa expression enhances cellular sensitivity to virus
ordsRNA-induced apoptosis. Herewedemonstrate thatNoxanull babymousekidney (BMK) cells are deﬁcient in
normal cytopathic response to lytic viruses, and that reconstitution of the knockout cells with wild-type Noxa
restored normal cytopathic responses. Noxa regulation by virusmirrored its regulation by proteasome inhibitors
or ER stress inducers and theERstress response inhibitor salubrinal protected cells against viral cytopathic effects.
Noxa mRNA and protein were synergistically upregulated by IFN or dsRNA when combined with ER stress
inducers, leading to Noxa/Mcl-1 interaction, activation of Bax and pro-apoptotic caspases, degradation of Mcl-1,
loss of mitochondrial membrane potential and initiation of apoptosis. These data highlight the importance of ER
stress in augmenting the expression of Noxa following viral infection.eaman).
unicable Diseases, University
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Activation of the innate and adaptive immune responses is critical to
survival of the host during virus infection. Production of type I
interferons (IFNs), including IFN-β and members of the IFN-α family,
is an obligatory component of the antiviral response (Stark et al., 1998).
Recognition of components of the viral genome or replicative in-
termediates, suchasdouble-strandedRNA(dsRNA) and single-stranded
RNA is carried out by a variety of intracellular receptors, which trigger
signaling cascades that culminate in the induction of target genes,
including type I IFNs and other inﬂammatory cytokines (Iwasaki and
Medzhitov, 2004). IFNs induce many genes that mediate cellular
antiviral responses by either directly inhibiting virus replication or
stimulating the adaptive immune system (Leaman et al., 2006). dsRNA
may also directly stimulate expression of many of the same genes
involved in the innate immune response (Bandyopadhyay et al., 1995).
Effective mechanisms for preventing viral replication, spread, and
persistence include inhibition of protein synthesis, protein transport,
and induction of apoptosis. Several IFN-regulated genes encodeproteins
that are important components of the antiviral response, including the
dsRNA-activated protein kinase R (PKR), RNase L, guanylate binding
protein 1 (Gbp-1), tumor necrosis factor-related apoptosis-inducing
ligand (TRAIL/Apo2L), cig 5 (viperin), and XIAP-1 associated factor-1
(XAF1) (Reviewed in Leaman et al., 2006; Chawla-Sarkar et al., 2003). Itis likely that theseproteins function to block virus replicationdirectly, as
in the case of PKR, RNase L, Gbp-1, and viperin, and indirectly by
promoting apoptosis of infected cells prior to completion of viral
replication, effectively limiting further virus infection (Haller et al.,
2007; Silverman, 2007; George et al., 2009). Upregulation of proteins
involved in sensing viral nucleic acids and priming components of the
adaptive immune response are also critical for a full antiviral response to
IFNs (Takeuchi and Akira, 2009).
Virus infection and replication not only stimulate innate immune
and inﬂammatory responses, but also cause stress to the endoplasmic
reticulum (ER; He, 2006). The ER is sensitive to imbalances in cellular
homeostasis, includingmassive protein production andmisfolding, loss
of calcium homeostasis, and inhibition of N-linked glycosylation
(Szegezdi et al., 2006). Replication of many viruses requires the
production of properly folded and heavily modiﬁed proteins, making
the ER an essential organelle for proper maturation of nascent viruses
(He, 2006). In response to ER stress, a complex adaptive process, termed
the unfolded protein response (UPR), is initiated to help reduce the
number of misfolded proteins, either by suppressing protein synthesis
or by elevating levels of proteins involved in folding and degradation
(Harding et al., 2002). A major component of the UPR is PKR-like ER
kinase (PERK), which down-regulates global protein translation by
phosphorylating eukaryotic translation initiating factor 2α (eIF2α). In
addition to the PERK-dependent pathway, activation of ATF6 and
Inositol-requiring enzyme 1 (IRE1) induces other mediators of the UPR,
including X box binding protein 1 (XBP1). When the cell is unable to
recover from extended ER stress, apoptotic signals, including upregula-
tion of C/EBP homologous protein (CHOP/GADD153), are initiated to
eliminate the stressed cell (Kaufman, 2002). Indeed, infection of cells by
various viruses can activate a canonical ER stress response including
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eventual induction of apoptosis in the infected cell (Yu et al., 2006;
Medigeshi et al., 2007; Barry et al., 2010), although someviruses combat
this process to allow production of large amounts of structural proteins
(He, 2006).
A small molecule pharmacologic inhibitor of ER stress response,
salubrinal, is able toblockmanyof the cytotoxic responses toER stress as
ameans to prevent cellular death (Boyce et al., 2005). Salubrinal inhibits
PP1-GADD34 phosphatase activity, thereby blocking eIF2α dephos-
phorylation and extending translational attenuation. It may also block
apoptotic responses downstream of the IRE1 and ATF6 transcription
factors, depending on the cellular context (Wiseman and Balch, 2005).
Salubrinal has been used to block cellular cytopathic responses to
Dengue andHerpes Simplex viruses (Boyce et al., 2005;Umareddy et al.,
2007), thereby implicating ER stress in the replication and cellular
response to some lytic viruses.
We have previously shown that Noxa, a mitochondrial BH3-only
member of the Bcl-2 family, is induced by virus infection or dsRNA and
can augment virus-induced apoptosis (Sun and Leaman, 2005). Noxa
was originally identiﬁed as a p53-regulated protein required for DNA
damage-induced apoptosis (Oda et al., 2000; Yakovlev et al., 2004), but
has subsequently been implicated in a variety of stress response
pathways (Ploner et al., 2009). Noxa expression can be upregulated by
dsRNA or virus infection in a p53-independent manner (Sun and
Leaman, 2005; Goubau et al., 2009), as well as by the ER stressors
tunicamycin and thapsigargin (Li et al., 2006). Noxa expression is also
rapidly upregulated in a number of different tumor cell lines by the
proteasome inhibitors bortezomib (velcade, PS-341) andMG132, again
independently of p53 status (Jüllig et al., 2006; Fennell et al., 2008).
Application of the synergistic upregulation of Noxa by proteasome
inhibitors, and other chemotherapeutics, and restoration of apoptotic
responsivenesshas recentlybeen the target of intense study in anumber
of refractory tumor types (Nikiforov et al., 2007; Zall et al., 2010; Kuroda
et al., 2010; Ri et al., 2010; Weber et al., 2009). Because virus infection
and proteasome inhibitors can both induce ER stress, we sought to
examine the effects of lytic viruses and viral mimetics, including the
combination of dsRNA and MG132 or other well-characterized ER
stressors (Lee et al., 2003), on Noxa regulation and cytopathicity. We
hypothesize that Noxa is a critical mediator of this response, which
represents a mechanism by which cells detect and respond to virus
infection via apoptosis.
In the present study, we show that lytic viruses can replicate in Noxa
null cells, but that viral CPE is dramatically reduced. The relative roles of
the dsRNA and ER stress-sensing pathways were examined and
suggested that ER stress is a more potent regulator of cellular
cytopathicity in response to lytic virus infection. We also show that
dsRNA synergizeswithMG132 to rapidly upregulateNoxa and augment
apoptosis, in a manner similar to VSV or EMCV infection. We observed
enhanced activation of caspase 3 and cell death in response to the
combination as compared to each individual treatment alone. We also
show activation of Bax, release of cytochrome c, degradation of Mcl-1,
and loss ofmitochondrialmembranepotential in response todsRNAand
MG132. Knockdown of Noxa levels using siRNA attenuated the pro-
apoptotic effects of dsRNA and MG132. Together, these data highlight
the importance of Noxa as an intermediate in both dsRNA- and ER
stress-dependent cellular cytopathic responses.
Results
Noxa induction by virus is required for enhanced apoptosis
Upregulation of Noxa expression is observed in a variety of cell types
in response to DNA damage, hypoxia and therapeutically relevant
proteasome inhibitors (Oda et al., 2000; Yakovlev et al., 2004; Kim et al.,
2004; Fernandez et al., 2005; Pérez-Galán et al., 2006). We have shown
previously that Noxa is upregulated by virus or dsRNA in a p53-independent, IRF-3-dependent manner (Sun and Leaman, 2005;
Goubau et al., 2009). To extend our analyses into Noxa's function in
cellular antiviral responses, immortalizedwild-type (WT)andNoxanull
(−/−) baby mouse kidney (BMK) epithelial cells were used in virus
replication and cytopathicity studies. To serve as reconstituted controls,
the Noxa knockout cells were stably transfected with empty plasmid
(−/− Vector) or wild-type Noxa (−/− Noxa) (Goubau et al., 2009).
Wild-type,−/−, −/− Vector and −/− Noxa BMK cells were infected
with VSV (moi 0.001) or EMCV (moi 0.01) for 16 h and assessed for
cytopathicity. Both virus types undergo 2–3 rounds of replication in this
timeframe in these cells (data not shown). Whereas WT and Noxa-
complemented cells were sensitive to VSV- or EMCV-induced cyto-
pathicity, Noxa null cells (unmodiﬁed or vector transfected) were
resistant (Figs. 1A, B). This phenotype was observed across multiple
vector or Noxa-complemented clonal lines (data not shown). The Noxa
null cells (−/− and−/−Vector) also showed reduced loss in viable cell
numbers after VSV or EMCV infection, as compared to theWT or Noxa-
complemented cells (Fig. 1C), and knockout cells exhibited less caspase
3 activation followingVSV infection (Fig. 1D), consistentwith our earlier
siRNA studies (Sun and Leaman, 2005).
The lack of viral CPE in the knockout cells could reﬂect a difference in
infectivity or defects in cellular response to the virus. To conﬁrm that the
−/− and −/− Vector cells were not deﬁcient in VSV adsorption or
uptake, viral replication was assessed in all cell lines by measuring viral
yields andVSVG-proteinmRNAaccumulation (Fig. 2A). Results indicated
that viral production in the knockout cells was reduced by about 10-fold
as compared toWT cells (Fig. 2Ai), but that viruswas still produced in the
knockout cells as indicated by VSV G mRNA accumulation in
cells (Fig. 2Aii). Similar data were obtained for EMCV (Supplemental
Figs. 1A–C). VSV G-protein expression was assessed by immunoﬂuores-
cence in infectedWT orNoxa null cells (Figs. 2B, C). After 16 h, staining in
theWT and knockout BMK cells was observed (Figs. 2B, C), but unlike the
WT BMK cells that died quickly thereafter, VSV G-protein expression
persisted beyond 96 h in the Noxa null cells (Fig. 2C). Even infectionwith
a high moi of VSV failed to induce death of the knockout cells
(Supplemental Fig. 2D), indicating that it was the lack of a cellular
death response, and not reduced viral replication rates, that lead to the
differences in cytopathic responses between the wild-type and Noxa
−/− cells. Together, these data suggested that loss of Noxa blocked
cellular apoptosis but did not prevent virus replication or persistence.
Involvement of ER stress pathways in Noxa regulation and viral CPE
Although IRF3 is clearly involved in Noxa upregulation by dsRNA or
virus (Goubau et al., 2009), the response of Noxa null cells infectedwith
lytic viruses more closely mirrored the observed effects of proteasome
inhibitors or ER stress inducers, which preferentially kill Noxa-intact
versus knockout cells (Fig. 3A). Indeed, combined MG132/dsRNA
treatment of cells promoted cytopathic responses that were nearly
identical to those obtained with VSV infection (Fig. 3A). Thus, to
investigate a role for ER stress responses in the resistance of Noxa null
cells to lytic viruses, we treatedWT andNoxa null cells with VSV, EMCV,
thapsigargin (TG) or bortezomib and assessed Noxa mRNA expression.
Viral infectionor treatmentwithTGor bortezomib-inducedNoxamRNA
in WT BMK cells (Fig. 3Bi). CHOP/GADD153, a marker of ER stress that
mediates speciﬁc transcriptional responses to ER perturbation, was also
upregulated by virus infection, TG, and bortezomib treatment of WT
BMK cells (Fig. 3Bii). Importantly, CHOP was also upregulated in the
Noxa null cells (Fig. 3Bii), indicating that the upstream components of
the ER stress responsewere intact in these cells. In addition to Noxa and
CHOP, ATF4 was similarly induced by these treatments (Supplemental
Figs. 2A, B). Other BH3-only proteins, including Bim and PUMA have
been implicated in virus-induced apoptosis. We found that both PUMA
and Bim were induced by dsRNA and weakly by virus, but not by ER
stressors (Supplemental Fig. 2D). Furthermore, both were still induced
in the Noxa null cells that resisted virus-induced cytopathicity
Fig. 1. Noxa null cells resist viral cytopathicity. A) Wild-type (WT) BMK cells, Noxa−/− cells, Noxa−/− cells transfected with empty vector and Noxa−/− cells stably expressing
wild-type Noxa were left untreated or infected with VSV (moi=0.001) or EMCV (moi=0.01) for 16 h. After that time, photomicrographs were taken to illustrate viral CPE in wild-
type and Noxa-complemented, but not Noxa null or vector-complemented cells. B) The same cells as in “A” were infected with VSV (moi=0.01 or 0.001) or EMCV (moi=0.1 or
0.01) for 16 h and then ﬁxed and remaining cell monolayers stained with crystal violet. C) To quantify cellular viability, cells were left untreated or infected with VSV or EMCV as in
“A” and after 16 h ﬁxed in TCA and stained with SRB. To quantify relative cell numbers, incorporated dye was eluted and absorbance quantiﬁed (OD 550 nm). Cell viability for each
sample was expressed as a percentage of the staining in the untreated cells. D) To assess apoptosis, cells were lysed at the indicate times after infection and caspase 3 cleavage was
monitored by immunoblotting.
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pro-apoptotic effects that these proteins may exert in this cell type.
To further investigate the importance of the ER stress versus the
dsRNA sensing pathway in upregulating Noxa expression following
virus infection, WT BMK cells were infected with replication active or
UV-inactivated VSV. Activation of IRF3 upon viral entry, but in the
absenceof replication, is sufﬁcient to induce an innate immune response
(Collins et al., 2004). While infection with active VSV elicited a normal
CPE response, including cell rounding, loss of viable cell numbers and
activation of caspase 3 (Fig. 3C), infection with UV-inactivated VSV had
no effect on cell viability (Fig. 3C). Nevertheless, the UV-inactivated
virus did infect the cells as demonstrated by RT-PCR of VSV G mRNA
(Fig. 3D), but it did not produce progeny or induce cell death. As
expected, CHOPmRNAwas only weakly induced by the UV-inactivated
virus (Fig. 3D). Noxa similarly showed little or noupregulation,whereas
the dsRNA-responsive ISG56 mRNA was upregulated strongly by both
wild-type and UV-inactivated VSV (Fig. 3D). These data suggest that ER
stress pathways that are activated in response to virus infection play an
important role in Noxa induction in infected cells.
To determine whether the ER stress pathways that upregulate Noxa
and CHOP are required to elicit virus-induced CPE responses in cells, the
ER stress inhibitor salubrinal was employed. Salubrinal is proposed toinhibit ER stress signaling by blocking cellular phosphatase complexes
that dephosphorylate eIF2α, preventing the ER stress response and
subsequent cell death (Boyce et al., 2005). In WT BMK cells, salubrinal
pretreatment was able to partially or fully block upregulation of CHOP
andNoxa by all of the stimuli tested (Figs. 4Ai, ii). Salubrinal is proposed
to act downstream of PERK phosphorylation, and immunoblot analysis
conﬁrmed that PERKphosphorylationwasnot affected in the salubrinal-
treated cells (Fig. 4Aiii). Importantly, salubrinal was able to protect cells
fromCPE (Figs. 4Bi, ii) and apoptosis (Fig. 4C) inducedby the viruses and
ER stress activators employed in these studies. As with loss of Noxa,
salubrinal did not fully prevent virus infection or replication (Fig. 4Biii),
and cells did eventually succumb to cytopathic effects (data not shown).
Nevertheless, these data demonstrate a role for ER stress in the
immediate cytopathic response to lytic viruses such as VSV or EMCV.
Noxa upregulation correlates with enhanced apoptosis typiﬁed by
mitochondrial dysfunction
Our data suggest that ER stress is an important contributor to Noxa
induction and virus-induced CPE. Previous studies had clearly indicated
that dsRNA can directly stimulate Noxa expression (Sun and Leaman,
2005;Goubauet al., 2009). Although the studies conductedhere suggest
Fig. 2. Viral replication in WT and−/− cells. A) i. The indicated BMK cell lines were infected with VSV (moi=0.001 or 0.0001) for 16 h, the conditioned mediumwas harvested and
applied to indicator HT1080 cells in Log10 dilutions. After an additional 16–24 h, indicator cells were ﬁxed and stained with crystal violet and viral titers quantiﬁed as the dilution
providing 50% cytopathicity, and expressed as a value relative to that observed in WT BMK infected with moi=0.001. ii. To assess viral RNA accumulation, cells were infected with
VSV (moi=0.001) for 0–96 h and then total cellular RNA was isolated and reverse transcribed into cDNA that was used as a template for RT-PCR analysis of VSV G-protein mRNA
expression. GAPDH served as a cellular RNA control. B) WT BMK cells were infected with VSV (moi=0.001) for 16 h and then ﬁxed and stained for immunoﬂuorescent detection of
VSV using a G-protein primary antibody and a FITC-conjugated goat anti-mouse secondary antibody. Cellular morphology was assessed by phase contrast microscopy, and cell nuclei
were detected by DAPI staining. C) Noxa −/− BMK were infected with VSV for 16 h or 96 h and then ﬁxed and stained as in “B”.
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expression, we sought to determine which aspects of virus infection
stimulated Noxa transcription. In particular, we investigated whether
dsRNA plus ER stress stimuli could mimic a virus infection and
combinatorially upregulate Noxa expression. Treatment of A375
melanoma cells with IFN-β, dsRNA, or MG132 alone or in combination
led to Noxa upregulation (Fig. 5A, see also Supplemental Fig. 3A). The
combinationof dsRNAandMG132 synergistically upregulatedNoxa and
this corresponded to enhanced caspase 3 activation and cell death
(Fig. 5A, lane 6) versus treatment with either stimulus alone. Similar
results were obtained with Thapsigargin and dsRNA (data not shown).
In all cells tested, upregulation of Noxa by virus, dsRNA, MG132, or TG
occurred at the transcriptional level (Fig. 4A, Supplemental Figs. 3B, C)
and was not simply due to MG132-mediated stabilization of protein.
CHOP andGADD34were assessed in parallel as additionalmarkers of ER
stress (Supplemental Fig. 3B).
The mechanism of Noxa-induced cell death has been well
characterized (Shibue et al., 2003; Villunger et al., 2003; Seo et al.,2003). Noxa binds to the anti-apoptotic Bcl-2 family member Mcl-1
(Willis et al., 2005; Chen et al., 2005). This results in the displacement of
sequestered Bax and Bak, which allows for their activation and the
degradation of Mcl-1. Once activated, Bax and Bak oligomerize to form
pores in the outermitochondrialmembrane that promote the release of
cytochrome c and activation of caspases, which then cleave intracellular
targets and promote the morphological changes associated with
apoptosis. To investigate the mechanism of Noxa-induced cell death
in response to virus infection and ER stress, A375 cells treated with
dsRNA and MG132 were lysed to immunoprecipitate Mcl-1 to assess
Noxa and Mcl-1 association. Interestingly, we found an interaction
between Noxa and Mcl-1 in both untreated and treated cells. Over the
6 h time course, Noxa protein levels increased and we eventually
observed cleavage of Mcl-1 (Fig. 5Bi). Replicate samples were used to
immunoprecipitate active Bax using an active state-speciﬁcmonoclonal
antibody. Levels of active Bax increased signiﬁcantly after 2 and 6 h of
treatment with dsRNA and MG132 (Fig. 5Bi). We have been unable to
detect an interaction between either Bak or inactive Bax and the Noxa-
Fig. 3. Role of ER stress response in Noxamode of action. A)WT BMK cells,−/− cells,−/− cells transfected with empty vector and−/− cells stably expressing wild-type Noxa were
left untreated or treated with bortezomib (16 h, 20 nM), MG132 (6 h, 10 μM), MG132+poly IC (6 h, 100 μg/ml) or infected with VSV (16 h, moi=0.001). After treatment, cells were
photographed under phase contrast microscopy to illustrate morphological changes associated with those treatments. B) i. WT and−/− BMK cells were left untreated, infected with
VSV (moi=0.001) or EMCV (moi=0.01) for 16 h, or treated with thapsigargin (TG; 1 μm) or bortezomib (20 nM) for 16 h. RNA was isolated and RT-PCR studies were performed
using primers speciﬁc for mouse Noxa and mouse GAPDH as a loading control. ii. CHOP (a marker of ER stress) mRNA levels were quantiﬁed by using real time SYBR green-based
qRT-PCR. C) i. WT BMK cells were left uninfected or were infected with replication competent VSV (moi=0.001) or UV-inactivated VSV (moi=0.1) for 16 h, after which time
photomicrographs of the cells were taken under phase contrast microscopy. ii. Viability of cells treated as in “i” was determined by SRB staining, and results were presented as a
percentage of the staining observed in uninfected controls. iii. Cells were infected as above and apoptosis demonstrated by immunoblot analysis of caspase 3 cleavage. D) Induction
of ER stress-regulated and dsRNA-regulated genes was assessed by RT-PCR analysis of WT BMK cells infected with either wild-type VSV (moi=0.001) or UV-inactivated virus
(moi=0.1) 16 h after infection. Mouse GAPDH was used as an internal control.
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for immunoprecipitating active Bax or Mcl-1 was fractionated into
mitochondrial and cytosolic extracts to monitor the release of
cytochrome c. Not surprisingly, the activation of Bax and degradation
of Mcl-1 also corresponded to an increase in cytosolic cytochrome c
(Fig. 5Bi). We also analyzed the cleavage and activation of caspase 3 in
whole-cell lysates of the same samples. At 6 h of treatment with dsRNA
andMG132, where levels of active Bax, Mcl-1 cleavage, and cytochrome
c release are highest, activation of caspase 3 is also seen (Fig. 5Bi). There
was no change in total levels of Bax, Bak, or Bcl-2, underscoring the
importance of the Noxa-Mcl-1 interaction and subsequent degradation
of Mcl-1 in the setting of ER stress.
To conﬁrm that the observed effects on Bax activation and
cytochrome c release in response to ER stress appropriately mimicked
virus infection, A375 cells were infected with either VSV or EMCV, or
treatedwith TG. After 16 h of treatment, cellswere harvested and eitherlysed to immunoprecipitate activeBaxor fractionated todetect cytosolic
levels of cytochrome c. In agreement with dsRNA/MG132 treatment, all
three stimuli promoted activation of Bax and concomitant release of
cytochrome c from the mitochondria into the cytosol (Fig. 5Bii). The
mitochondrial marker COX IV was assessed in parallel experiments,
conﬁrming the purity of cellular fractions employed in these studies
(Supplemental Fig. 3D).
Activation of pro-apoptotic Bcl-2 family members leads to permea-
bilization of the outer mitochondrial membrane, release of key
mediators for augmenting the apoptotic response, and, from a
biochemical standpoint, leads to depolarization of the inner mitochon-
drial membrane. To extend our studies on the effects of Noxa induction
on apoptosis, we used a potentiometric dye, TMRE, to measure
mitochondrial membrane potential in A375 cells treated with dsRNA
and MG132. In line with our previous mechanistic data, the increase in
apoptosis also corresponded to a loss of mitochondrial membrane
Fig. 4. Inhibition of ER stress response blocks Noxa upregulation and viral CPE. A) i. WT BMK cells were left untreated (Ctrl) or were infected with VSV (16 h, moi=0.001), EMCV
(16 h, moi=0.01), TG (16 h, 1 μM) or bortezomib (16 h, 20 nM) with or without prior treatment with the ER stress inhibitor salubrinal (Sal; 75 μM, 24 h). Total cellular RNA was
then isolated and reverse transcribed for RT-PCR analysis of CHOP and Noxa mRNA induction. GAPDH was used as an internal control. ii. To quantify CHOP and Noxa mRNA
expression, SYBR green-based qRT-PCR was used and the values were normalized to GAPDH. B) i. WT BMK cells were infected with VSV or EMCV or treated with TG, with or without
Sal (75 μM) pretreatment. After 16 h, photomicrographs were taken to illustrate morphological changes associated with VSV, EMCV and TG cytopathicity.
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dsRNA/MG132-induced apoptosis, we transfected cells with either
control or Noxa-speciﬁc siRNA to reduce levels of the endogenous
protein. In accordancewithprevious observations, knockingdownNoxa
resulted in an approximately 50% reduction in cell death, loss of
mitochondrial membrane potential, and caspase 3 activation (Figs. 5Ci
and Cii; Jüllig et al., 2006). These data paralleled our earlier observations
that Noxa knockdown reduced EMCV-induced apoptosis (Sun and
Leaman, 2005).
Discussion
The role of cellular apoptosis in the dissemination of viral progeny
within an infectedhost is complex.Many lytic viruses induce apoptosis as
part of the normal replication process as a means to move beyond the
infected cell. However, host factors, rather than virus-encoded proteins,
appear to be the primary initiators of cellular apoptosis. This host innate
immune response utilizes apoptotic mechanisms to minimize virus
damage and prevent long term infections. A number of cellular factors
have been implicated in modulating viral CPE (apoptotic) effects. These
include PKR, TRAIL and PML, each of which are upregulated by virus
infection directly or through IFN feedback and have been implicated in
virus-induced apoptotic responses (Barber, 2001). However, othersmust
certainly play a role in determiningwhether a cell ultimately undergoes a
cytopathic response or survives the initial infection. Our data suggest thatNoxa is another example of a host factor that is required for appropriate
cellular apoptotic responsiveness to viral stresses.
Noxa is potentlyupregulatedbydsRNA, IFNandviruswithin3–6 hof
treatment (Sun and Leaman, 2005; Goubau et al., 2009), and the
upregulation by virus or dsRNA does not require IFN (Sun and Leaman,
2005) or p53 (Sun and Leaman, 2005; Lallemand et al., 2007) as an
intermediate. Upregulation by virus or dsRNA clearly involved IRF3
regulated mechanisms: Noxa was robustly induced by adenovirally-
expressed IRF3 5D, a constitutively active formof IRF3, and its induction
by dsRNA was defective in IRF3 null MEFs (Goubau et al., 2009).
Expression of a Noxa promoter/luciferase construct was upregulated by
IRF3 5D, and IRF3 was recruited to the Noxa promoter following dsRNA
treatment (Goubau et al., 2009). In contrast, IRF7 was only weakly able
to induce Noxa expression (Goubau et al., 2009). Thus, IRF3 clearly can
induce Noxa following virus infection. However, while IRF3-null cells
are not deﬁcient in virus-induced apoptosis (Sato et al., 2000), Noxa null
cells were unable to mount a normal CPE response to VSV or EMCV
(Fig. 1), suggesting that Noxa plays a prominent role in virus-induced
apoptosis and that factors other than IRF3 are involved in its regulation.
Studies conducted herein with UV-inactivated virus supported this
observation and implicated other virus-induced pathways in the
regulation of Noxa and viral CPE responses.
Although Noxa was originally implicated as an integral component
of the p53-dependent response to DNA damage or hypoxia (Oda et al.,
2000), a number of recent studies have demonstrated the signiﬁcance of
Fig. 5. Noxa mechanism of action in MG132/dsRNA treated A375 cells. A) Immunoblot analysis of Noxa upregulation by IFN-β (1000 U/mL, 16 h), dsRNA (poly IC, 100 μg/mL, 6 h),
MG132 (10 μM, 6 h) and combinations thereof in A375 melanoma cells. Because of the signiﬁcant synergistic increase in Noxa protein levels, as compared to single treatments, a
short exposure was chosen for the clearest representation of all samples. Cell death was qualitatively assessed by immunoblotting for caspase 3 and quantiﬁed by assessing the
number of trypan blue positive cells. B) i. Mcl-1 was immunoprecipitated from cells treated for the indicated times and Noxa association was assessed by immunoblotting. Noxa was
associated with Mcl-1 basally and exhibited enhanced association with treatment, combined with Mcl-1 cleavage (ns=non-speciﬁc; arrowheads=cleaved forms). Replicate
samples were used to immunoprecipitate Bax with the active conformation-speciﬁc 6A7 antibody, followed by immunoblotting to show Bax activation upon MG132/dsRNA
treatment. Fractionation of cells to generate post-mitochondrial cytosolic extracts was used to assess the presence of released cytochrome c. A parallel study was done showing Noxa
upregulation, caspase 3 activation and Mcl-1 cleavage in whole-cell lysates (WCL). Bax, Bcl-2, and Bak blots are provided to show lack of change in the levels of these proteins. ii.
A375 melanoma cells were left untreated or infected with VSV (16 h, moi=0.001) or EMCV (16 h, moi=0.01), or treated with TG (16 h, 1 μM). As described in “i”, cells were
harvested for either immunoprecipitating active Bax or fractionated to assess the presence of cytochrome c in post-mitochondrial cytosolic extracts. C) i. Cells were reverse
transfected with control or Noxa-speciﬁc siRNAs and treated for up to 6 h with dsRNA andMG132. After treatment, cells were stained with TMRE (10 μM) and then analyzed by ﬂow
cytometry to detect changes in mitochondrial membrane potential. Treatment of a subset of control cells with the protonophore CCCP was used to set the marker for the TMRE-low
population. The percentage of cells with depolarizedmitochondrial membranes is indicated in each histogram. ii. A portion of cells not subjected to ﬂow cytometry was also analyzed
for cell death by immunoblotting for caspase 3 and staining with trypan blue. Successful knockdown of Noxa was also conﬁrmed by immunoblotting.
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inhibition and ER stress. Proteasome inhibitors were originally
developed to counteract the aberrant activation of classical NF-κB
signaling (Traenckner et al., 1994; Grivennikov et al., 2010) by
preventing the proteasome-dependent degradation of IκBα. In addition
to the NF-κB-inhibitory effects, treatment with proteasome inhibitors
also promoted expression and activation of pro-apoptotic BH3-only
proteins including Noxa, Bid, and Puma (Fennell et al., 2008). In
particular, induction of Noxa in response to bortezomib treatment has
been reported in a wide variety of tumor cell types and serves as a
prognostic indicator for the efﬁcacy of treatment (Pérez-Galán et al.,
2006; Ri et al., 2009; Gomez-Bougie et al., 2007; Chen et al., 2010;Nikiforov et al., 2007). Rapid induction of Noxa by bortezomib
correlated with a signiﬁcant increase in apoptosis in melanoma, but
not in normal keratinocytes (Fernandez et al., 2006), and shRNA-
dependent knockdown of Noxa attenuated bortezomib-induced cyto-
toxicity (Pérez-Galán et al., 2006). Overall, proteasome inhibitor-
dependent upregulation of Noxa has been used synergistically with
other therapeutics to maximize the induction of tumor cell death (Kim
et al., 2010; Ackler et al., in press; Zall et al., 2010; Weber et al., 2009).
An important consequence of treating cells with proteasome
inhibitors is the accumulation of improperly folded ormodiﬁedproteins
within the ER, leading to ER stress. A cytoprotective activity, known as
theunfoldedprotein response (UPR), is initiated topromote refolding or
Fig. 6. Model for Noxa induction by virus and other stimuli: involvement of ER Stress
responses. The data presented in this and previous reports suggest that Noxa is
regulated by virus through both IRF3-dependent regulation and ER stress-induced
pathways. Of these, our data suggest that ER stress response signaling is most critical for
Noxa regulation. These same pathways are also known to mediate Noxa induction by
other ER stressors, including proteasome inhibition, thapsigargin or tunicamycin. In
tumor cells, it has been proposed that c-myc also regulates Noxa expression following
proteasome inhibition (Nikiforov et al., 2007).
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induction of apoptosis if the aggregation of faulty proteins cannot be
resolved. ER stress-induced apoptosis depends on pro-apoptotic Bcl-2
familymembers, includingNoxa andBax, and activationof caspases (Lai
et al., 2006). Once activated Bax/Bak oligomerize and promote the
release of cytochrome c and activation of caspases 9 and 3 through
permeabilization of the outer mitochondrial membrane (Adams and
Cory, 2007).Mcl-1 is then subject to degradation by caspases, enhancing
the apoptotic signal. Indeed, Mcl-1 downregulation can promote
activation of Bax and Bak (Adams and Cooper, 2007). Mcl-1 levels are
regulated both transcriptionally and translationally, and Mcl-1 protein
is subject to rapid turnover (Fritsch et al., 2007). Cells that express high
levels of Mcl-1 are resistant to proteasome inhibitor-induced cell death
(Jiang et al., 2008). However, concomitant upregulation of Noxa and
downregulation of Mcl-1 using siRNA or BH3 mimetics promotes
apoptosis in resistant cells, suggesting that a balance in favor of
increased Noxa activity is required for optimal killing (Zall et al., 2010;
Weber et al., 2009). Upregulation of Noxa in response to the ER stressors
thapsigargin and tunicamycin correlates with the induction of apopto-
sis, while MEFs lacking both Bax and Bak are resistant to apoptosis
inducedby thapsigargin, tunicamycin, andbrefeldinA (Wei et al., 2001).
These data implicate Bax/Bak in Noxa-mediated effects on ER stress-
induced apoptosis. Our results are consistent with this, and a recent
report emphasizing the importance of Mcl-1 degradation in VSV-
induced apoptosis (Pearce and Lyles, 2009), although that study
suggested that Bid also played an important role in the process. Other
BH3-only proteins, including Bim and PUMA have been implicated in
viral cytopathic responses (Perfettini et al., 2004; Puthalakath et al.,
2007). While our results were consistent with their upregulation by
virus and dsRNA, this inductionwas also observed inNoxa null cells that
were resistant to virus-induced cytopathicity (Suppl. Fig. 2). While this
does not rule out a role for these proteins in innate immune response to
virus, it does imply that they are either less critical thanNoxa, or at least
insufﬁcient to replace the loss of Noxa in these cells.
Because of the importance of Noxa in mediating ER stress responses,
we assessed the role of virus-associated ER stress in promoting Noxa
expression and cellular apoptosis. Virus infection and replication are
well-known inducers of ER stress and apoptosis (He, 2006; Yu et al.,
2006; Medigeshi et al., 2007; Barry et al., 2010). Viruses rely on the
infected host cell machinery, namely the ER, to fold and modify proteins
for productive replication. VSV, in particular, produces large amounts of
G-protein that is modiﬁed through the ER/golgi apparatus. Our studies
using UV-inactivated VSV demonstrate that, although the defective virus
was still able to infect BMKcells, itwas unable to induceNoxa expression,
presumably due to its inability to replicate or induce ER stress.
Furthermore, treatment with an ER stress signaling inhibitor, salubrinal,
prevented not only the upregulation of Noxa in response to virus
infection, proteasome inhibition, and direct ER stressors, but also blocked
virus-induced cytopathic effects and ER stress-induced apoptosis.
Although salubrinal exhibits some non-speciﬁc effects, particularly
those that result from its ability to reduce protein synthesis, the results
obtained with this inhibitor were consistent with those observed in the
Noxa knockout cells, suggesting that least a portion of the resulting
phenotypes (i.e. reduced CPE in Noxa −/− or salubrinal-treated cells)
was due to reduced ER stress responses. Additional studies with future,
more speciﬁc ER stress inhibitors will be required to conﬁrm the relative
contribution of the UPR in this process. Similarly, our studies demon-
strated that cells lackingNoxawere also devoid of cytopathic effects after
the induction of ER stress by virus infection and therapeutics.
The data presented here suggest that both ER stress and dsRNA
pathways are crucial for optimal Noxa induction by virus (Fig. 6). Noxa
in turn promotes Mcl-1 degradation and, presumably, Bax or Bak
oligomerization, which promotes mitochondrial outer membrane
permeabilization leading to cytochrome c release and apoptosis.
Although the precise transcriptional regulators downstream of the
unfolded protein response that regulate Noxa transcriptional inductionwere not identiﬁed in this study, it is likely that transcription factors
such as ATF3/ATF4 (Wang et al., 2009), p38 (Hassan et al., 2008) and
other stress-activated regulators are involved. Although c-myc has been
implicated in the regulation of Noxa by proteasome inhibitors
(Nikiforov et al., 2007; Fig. 6), we did not observe a change in c-myc
expression thatwould be consistentwith a role in Noxa induction in the
BMK cells examined here (data not shown). Thus, c-myc's role in
regulating Noxa may be most prominent in tumor cells, as suggested
previously by others (Nikiforov et al., 2007). Regulation via these
coordinated pathways ultimately promotes sufﬁcient Noxa expression
to displace pro-apoptotic factors fromMcl-1 and tip the balance in favor
of cell death. Although we feel that Noxa plays a critical role in this
determination, ourmodel is not intended to imply thatNoxa is therefore
both necessary and sufﬁcient for the process. Other factors, such as IRF-
3, MAVS, caspase 8 and Bid, clearly must coordinate with Noxa to
regulate cell death or survival, and different cell types may depend on
Noxa to a greater or lesser extent (Barber, 2001; Yu et al., 2010;
Chattopadhyay et al., 2011). Nevertheless, our data strongly connect
Noxa to virus-induced cellular damage and, potentially, to viral
persistence because failure to rid the body of infected cells could sustain
the infection and/or reduce adaptive immune responses. These results
are also relevant to the use of oncolytic viruses aimed at speciﬁcally
targeting tumor cells (Barber, 2005). Since Noxa expression may be
more strongly impacted in tumor cells as compared to normal cells, its
analysis may provide a prognostic marker for anti-tumor effectiveness
in lytic virus-based tumor therapies.Conclusions
These studies provide evidence that Noxa is a critical component of
ER stress-induced apoptosis and cytopathic responses in virally infected
cells. Although ER stress is a known product of virus infection, the
speciﬁc identities of genes activated through this response that regulate
viral cytopathicity and dissemination are less well characterized. Our
data for theﬁrst time clearly implicate Noxa as a downstreameffector of
the ER stress pathway in virally infected cells, and suggest that loss of
this response could lead to a state of persistent infection.
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Cells and reagents
A375 melanoma and HT1080 ﬁbrosarcoma cells have been
described before (Muller et al., 1993; Kohlhuber et al., 1997). Wild-
type and Noxa null baby mouse kidney cells (a generous gift from
Eileen White, Rutgers University) were maintained in Dulbecco's
modiﬁed Eagles medium containing 8% fetal bovine serum. IFN-β
(Serono), dsRNA (poly(I)-poly(C); GE Healthcare), MG132 (Z-Leu-
Leu-Leu-H aldehyde; Peptides International), thapsigargin (Sigma
Aldrich), Tuncamycin (Sigma Aldrich), Bortezomib (LC Laboratories)
and salubrinal (Tocris Bioscience) were used at the concentrations
described in the text. Noxa expression plasmids have been described
previously (Sun and Leaman, 2005). In addition to the antibodies
described in the following methods, we also used commercial
antibodies to P-PERK (Cell Signaling), Cox IV (Molecular Probes)
and alpha actin (Cell Signaling) in the reported studies.
RNAi
Control or Noxa-speciﬁc siRNAs were obtained as a pool of four
targeting siRNA duplexes (On-Target plus SMART pool; Dharmacon).
A375 cells were reverse transfected with control or Noxa siRNAs using
Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer's
recommendations. Knockdown of Noxawas conﬁrmed byWestern blot
using a Noxa monoclonal antibody (Alexis Biochemicals).
Assessment of cell viability and apoptosis induction
To determine cell viability, replicate plates were stained with
sulforhodamine B (SRB) as described previously (Sun and Leaman,
2005). Brieﬂy, cells were ﬁxed with 10% TCA for 15 min, then stained
with SRB solution (0.4% in 1% acetic acid) for 15–30 min and washed
four timeswith1%acetic acid. After drying, thedyewaseluted in 10 mM
unbuffered Tris and the absorbance was read on a plate reader at
550 nm.
For immunoblot analysis of caspase 3 cleavage,ﬂoatingandadherent
cells were lysed in RIPA buffer (150 mM NaCl, 1% NP-40, 0.5% sodium
deoxycholate, 0.1% SDS, 50 mM Tris pH 8.0, 1 mM PMSF), and proteins
were separated on 10–15% SDS-PAGE, electrotransferred to Immobilon-
P PVDF membrane (Millipore Corp.), and caspase 3 was detected by
probing with an antibody for caspase 3 (Cell Signaling). Cytochrome c
release from the mitochondria was assessed by fractionating adherent
and ﬂoating cells into mitochondrial and cytoplasmic extracts. Brieﬂy,
the cell pellet was resuspended in 5 volumes of mitochondrial isolation
buffer (MIB; 220 mMmannitol, 68 mM sucrose, 10 mM HEPES pH 7.4,
10 mM KCl, 1 mM EGTA, 1 mM EDTA, 1 mM MgCl2) then dounce
homogenized. The homogenate was centrifuged at 1000 g for 10 min.
The low-speed pellet was washed once in MIB and spun again. Low-
speed supernatants were pooled and centrifuged at 10,000 g for 10 min
to generate the crude mitochondrial pellet and cytoplasmic extract
(supernatant).
To assess changes in mitochondrial potential, A375 cells were
treatedwithdsRNA andMG132 for up to 6 h, and then analyzed by FACS
following tetramethylrhodamine ethyl ester (TMRE, Molecular Probes;
10 μM) staining. Treatment of cells with the protonophore carbonyl
cyanidem-chlorophenyl hydrazone (CCCP) was used as a control to set
the marker for the TMRE-low population. TMRE ﬂuorescence was
quantiﬁed on a FACS Calibur ﬂow cytometer (Becton Dickinson) using
Cell Quest software.
Immunoprecipitations
For Bax activation and Mcl-1 immunoprecipitations, cells were
treated as described above, harvested and lysed in CHAPS buffer(10 mM HEPES pH 7.4, 150 mM NaCl, 1% CHAPS) by three rounds of
freeze–thaw. Cleared lysates (500 μg total protein)were incubatedwith
2 μg of the Bax activation state-speciﬁc monoclonal antibody (6A7;
Trevigen) or 1 μg of Mcl-1 monoclonal antibody (RC13; Lab Vision
Corporation) for 2 h, after which protein G sepharose beads (GE
Healthcare) were added and incubated for an additional 1 h. The beads
werewashed three timeswithCHAPS lysis buffer and SDS loadingbuffer
was used to elute immune complexes. After SDS-PAGE and transfer,
blots were probed with polyclonal antisera to Bax (BD Pharmingen),
Mcl-1 (S-19; Santa Cruz Biotechnology) or with a monoclonal antibody
to Noxa, where appropriate.
Immunoﬂuorescence
For immunoﬂuorescence detection of VSV, wild-type and Noxa null
BMK cells were seeded on poly-L-lysine coated coverslips for 24 h and
then infected with VSV (moi=0.001) for 16 h (both BMK lines) or 96 h
(Noxa null BMK only). Coverslipswere thenwashedwith PBS and ﬁxed
with 4% paraformaldehyde in PBS for 15 min, permeabilized with 0.2%
Triton X-100 for 3 min and then blockedwith 5% bovine serum albumin
(BSA) for 15 min. Cells were incubated with rabbit anti VSV G (Sigma
Aldrich) primary antibody (1:1000 dilution) for 2 h at room temper-
ature, washed and then incubated with ﬂuorescein isothiocyanate-
conjugated goat anti-rabbit (Sigma Aldrich) secondary antibody (1:200
dilution) for 1 h at room temperature. Cover slips were mounted on to
glass slides in Vectashield (Vector Laboratories) containing 4′,6-
diamidino-2-phenylindole (DAPI). Fluorescent images were captured
on an Olympus 1×51 ﬂuorescent microscope. Additional studies were
performed with higher moi (Supplemental Fig. 1) following the above
staining procedures.
Virus infection and yield assays
Wild-type BMK cells, Noxa null cells, Noxa null cells stably
transfectedwithemptyvector, andNoxanull cells stably complemented
with Noxa were plated on 6 cm dishes for 24 h and infected with
laboratory stocks of VSV (Indiana strain) or EMCVat anmoi of 0.001 and
0.01 for 1 h in serum free media. After 1 h, the cells were washed with
PBS and 2 mL of completemediawas added. On the subsequent day, the
virus-infected media was harvested and centrifuged for 3–4 min at
4000 g. For viral yield assays, the clariﬁed supernatants were used to
infect an indicator cell line (HT1080 ﬁbrosarcoma cells) at 1:10 serial
dilutions. The next day, cells were ﬁxed in 100% methanol for 10 min
and stainedwith crystal violet for 5 min. Quantiﬁed results, plotted on a
log scale, represented the dilution at which 50% cell lysis was observed.
For UV inactivation of virus, high concentration stocks of VSV were
exposed to UV light for 15 s in a 6 cm dish using a Stratagene UV
Stratalinker 1800 (6000 μJ/cm2). Cells were infected with the inacti-
vated virus at a moi of 0.1.
RNA isolation and RT-PCR
Total cellular RNAwas isolated using Trizol reagent (Invitrogen, CA)
according to the manufacturer's instructions and reverse transcribed
(RT) with Moloney murine leukemia virus (MMLV) reverse transcrip-
tase (Fisher scientiﬁc, NJ). For virus-infected cells, both ﬂoating and
attached cells were harvested for RNA isolation. RT reactions utilized
1 μg of total cellular RNA, which was incubated with 1 μg of random
hexamer primers at 70 °C for 10 min then quick chilled on ice. Reactions
included dNTPs (1.25 mM), ribonuclease inhibitor (RNasin, 40 U;
Promega Corp., CA) and MMLV reverse transcriptase (200 U, Fisher
scientiﬁc, NJ) and were incubated at 42 °C for 1 h. The resulting cDNA
was used a template for semi-quantitative PCR ampliﬁcation (25–30
cycles: 30 s at 94 °C, 30 s at 52 °C and 60 s at 72 °C). PCR products were
analyzed on 1% agarose gels, visualized with ethidium bromide and
digital images were inverted to give dark bands on a light background.
302 S. Rosebeck et al. / Virology 417 (2011) 293–303RT-PCR studies were conducted with iQ SYBR Green supermix (BioRad,
CA) using a two-step ampliﬁcation (94 °C, 30 s; at 60 °C for 60 s) on an
Eppendorf Real Plex thermocycler. Relative target gene expression was
calculated by the ΔΔCt method using GAPDH as an internal control.
Abbreviations
ATF Activation transcription factor
BH3 Bcl-2 homology domain
CHOP C/EBP homologous protein
dsRNA double-stranded RNA
eIF2α Eukaryotic translation initiating factor 2α
EMCV Encephalomyocarditis virus
ER Endoplasmic reticulum
GADD Growth arrest and DNA damage-inducible protein
IFN Interferon
IRE1 Inositol-requiring enzyme 1
PERK PKR-like ER Kinase
UPR Unfolded protein response
VSV Vesicular stomatitis virus
XBP1 X box binding protein 1
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.virol.2011.06.010.
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